Regenerative Medical Spa
- PRP Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Red Light Therapy
- Psoriasis Treatment
Orlando, FL
Orlando sits in a Central Florida corridor where patients often travel from surrounding counties for elective and cash-pay care. Stem cell and orthobiologic offerings here sit beside tourism-adjacent wellness clinics, sports-medicine practices serving active adults and athletes, medspas, and larger regional health systems. That mix makes comparison harder for people shopping stem cell therapy in Orlando, Florida.
This hub lists clinics that appear in our Directory for this city and treatment. Inclusion is not an endorsement, and listing order is not a paid ranking. Regenerated.com is free for patients. Organic relevance and published evidence signals are separate from any labeled Featured or Sponsored placement. Verified badges, when present, reflect credential checks (not spend).
When you evaluate Orlando stem cell options, ask what tissue or cell source is used, whether the protocol is same-day or culture-expanded, who performs the procedure, what outcomes are measured, and how adverse events are handled. Florida marketing frequently borrows research language. Interest in a mechanism is not the same as a proven disease-modifying therapy for your condition. Travel and hotel packages sometimes appear in ads; convenience is not clinical quality.
Prefer clinicians who can explain risks in plain language, document informed consent, and connect claims to published evidence grades rather than testimonials alone. Use adjacent Guides for mechanism literacy, then return here to browse Orlando listings and national treatment context.
Before you trust badges or counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
Florida cellular therapy providers are governed by 21 CFR Part 1271. Section 361 applies to minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 applies to products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND or BLA. Most stem cell, stromal vascular fraction, exosome, umbilical cord blood derived, and culture-expanded mesenchymal cell therapies marketed in Florida for orthopedic, neurologic, autoimmune, and longevity indications fall under Section 351 and lack FDA approval. Florida is a high-volume market, which has translated into elevated federal scrutiny.
Florida has been a primary target of FDA enforcement. In US v US Stem Cell Inc (2019), a federal court in Florida granted a permanent injunction against a Sunrise-based clinic for marketing unapproved stem cell products derived from adipose tissue. The Eleventh Circuit upheld the injunction in 2021. The FDA has issued multiple warning letters to Florida clinics offering exosome and umbilical cord-derived therapies. The Florida Department of Health and the Boards of Medicine and Osteopathic Medicine have disciplined physicians for unprofessional conduct tied to misleading regenerative medicine marketing. The Florida Attorney General has pursued deceptive trade practice claims under FDUTPA against stem cell clinics.
Available here
Nationwide
Stem Cell Therapy clinics across the US